These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4818162)

  • 1. Cyclical combination chemotherapy for advanced breast carcinoma.
    Canellos GP; Devita VT; Gold GL; Chabner BA; Schein PS; Young RC
    Br Med J; 1974 Feb; 1(5901):218-20. PubMed ID: 4818162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy for advanced breast cancer: response and effect on survival.
    Canellos GP; DeVita VT; Gold GL; Chabner BA; Schein PS; Young RC
    Ann Intern Med; 1976 Apr; 84(4):389-92. PubMed ID: 1259283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM; Bruntsch U; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
    Creech RH; Catalano RB; Mastrangelo MJ; Engstrom PF
    Cancer; 1975 Apr; 35(4):1101-7. PubMed ID: 1116103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in the treatment of advanced breast cancer.
    Rosner D; Nemoto T; Dao TL
    J Surg Oncol; 1976; 8(6):465-9. PubMed ID: 994508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M; Fernholz HJ; Frik W
    Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy in metastatic carcinoma of the breast. Results with a three-drug combination.
    Otis PT; Armentrout SA
    Cancer; 1975 Aug; 36(2):311-7. PubMed ID: 1157003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment].
    Waibel PJ; Jungi WF; Senn HJ
    Dtsch Med Wochenschr; 1983 Dec; 108(48):1827-32. PubMed ID: 6641535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH; Blom J; Tormey DC
    Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
    Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative chemotherapy for fungating breast cancer.
    Kumar A; Shah LL; Khanna S; Khanna NN
    J Surg Oncol; 1987 Dec; 36(4):295-8. PubMed ID: 3695536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB; White DR; Cooper MR; Richards F; Spurr CL
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.